<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>M2 Internship ‚Äì Research Project | Marianne Guilbard</title>

  <style>
    :root{
      --bg:#0d1117;
      --text:#c9d1d9;
      --muted:#8b949e;
      --line:#30363d;
      --link:#58a6ff;
    }

    *{ box-sizing:border-box; }

    body{
      margin:0;
      font-family: system-ui, -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Arial, sans-serif;
      background:var(--bg);
      color:var(--text);
    }

    .container{
      max-width: 900px;
      margin: 0 auto;
      padding: 48px 20px 70px;
    }

    h1{
      font-size: 36px;
      margin-bottom: 8px;
    }

    h2{
      margin-top: 36px;
      margin-bottom: 12px;
      font-size: 24px;
    }

    p{
      line-height: 1.65;
      margin-bottom: 14px;
      text-align: justify;
    }

    ul{
      margin-left: 18px;
      line-height: 1.6;
    }

    img{
      max-width: 100%;
      border-radius: 12px;
    }

    .center{ text-align:center; }

    .muted{
      color: var(--muted);
      font-size: 14px;
    }

    a{
      color: var(--link);
      text-decoration:none;
    }

    a:hover{
      text-decoration: underline;
    }

    hr{
      border:none;
      border-top:1px solid var(--line);
      margin: 40px 0;
    }

    .back{
      display: inline-block;
      margin-top: 32px;
      padding: 10px 14px;
      border: 1px solid var(--line);
      border-radius: 10px;
      color: var(--text);
      text-decoration:none;
    }

    .back:hover{
      background: rgba(255,255,255,0.08);
      text-decoration:none;
    }

    /* ===== TRANSLUCENT ACTION BUTTON (shared style) ===== */
    .action-btn{
      display: inline-flex;
      align-items: center;
      gap: 8px;
      padding: 10px 14px;
      border: 1px solid var(--line);
      border-radius: 12px;
      background: rgba(255,255,255,0.06);
      backdrop-filter: blur(6px);
      color: var(--text);
      text-decoration: none;
      font-size: 14px;
      transition: background 0.2s ease, transform 0.15s ease;
    }
    
    .action-btn:hover{
      background: rgba(255,255,255,0.12);
      text-decoration: none;
      transform: translateY(-1px);
    }

  </style>
</head>

<body>
  <div class="container">

    <h1>M2 Internship ‚Äì Research Project</h1>
    <p class="muted">Master 2 Internship ¬∑ Breast Cancer Biology ¬∑ AGR2 & Senescence</p>

    <p>
      Following my interest in breast cancer signaling pathways, I pivoted towards the study of protein chaperones where I Investigated the role of AGR2 in therapy-induced senescence (TIS) in breast cancer cells. 
    </p>

    <hr>

    <h2>üß™ Project Overview</h2>

    <p>
      The endoplasmic reticulum‚Äìresident protein AGR2 (Anterior Gradient 2), a member of the protein disulfide isomerase
      (PDI) family, is frequently overexpressed in breast cancer and implicated in tumor growth, invasion, and metastasis.
      In addition to its intracellular functions, AGR2 is secreted into the tumor microenvironment as extracellular AGR2
      (eAGR2), where it acts as a pro-oncogenic factor. Previous work from our team showed that inhibition of AGR2
      expression in lung cancer cells induces a senescent phenotype. Building on these observations, this project
      investigated the role of AGR2 in therapy-induced senescence (TIS) in breast cancer cells. We found that TIS leads to
      proliferative arrest, senescence entry, and a marked reduction of AGR2 at both intra- and extracellular levels.
      Importantly, supplementation with recombinant eAGR2 in doxorubicin-treated MCF7 cells significantly reduced
      senescence entry, indicating that extracellular AGR2 promotes escape from TIS. Overall, these results suggest that
      AGR2 contributes to resistance to therapy-induced senescence in breast cancer through its extracellular activity.
    </p>
    
    <h2>üß¨ Graphical Abstract</h2>

    <div class="center">
      <img src="M2-Figure2.jpg" alt="Graphical abstract ‚Äì AGR2 and therapy-induced senescence">
      <p class="muted">
        The secretion of extracellular AGR2 (eAGR2) facilitates escape from therapy-induced senescence (TIS),
        enabling breast cancer cells to sustain proliferative capacity.
      </p>
    </div>

    <h2>üî¨ Methods</h2>
    <ul>
      <li><strong>Cell culture:</strong> MCF7 breast cancer cell line</li>
      <li><strong>Functional assays:</strong> Senescence-associated Œ≤-galactosidase staining, cell proliferation assays</li>
      <li><strong>Protein analysis:</strong> Western blotting</li>
      <li><strong>Recombinant protein production:</strong> IPTG induction, thrombin cleavage, Coomassie-based quantification</li>
    </ul>

    <h2>üìÑ Full Report</h2>
    <p>
      The complete internship report is available here:
      <br>
      üëâ <a href="https://github.com/marianne-guilbard/marianne-cv/raw/main/M2%20report%20-%20marianne%20guilbard.pdf" target="_blank">
        Download M2 Internship Report (PDF)
      </a>
    </p>

    <hr>

    <a class="action-btn" href="index.html#research">‚Üê Back to main page</a>

  </div>
</body>
</html>
